gavreto
roche registration gmbh - pralsetinib - karcinom, ne-malih stanica pluća - antineoplastična sredstva - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
sapropterin dipharma
dipharma arzneimittel gmbh - Сапроптерин дигидрохлорид - phenylketonurias - drugi gastrointestinalni trakt i metabolizam, lijekovi, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
smofkabiven nutribase emulzija za infuziju
fresenius kabi d.o.o., radnička cesta 37a, zagreb, hrvatska - alanin arginin glicin histidin izoleucin leucin lizinacetat metionin fenilalanin prolin serin taurin treonin triptofan tirozin valin kalcijev klorid dihidrat natrijev glicerofosfat hidrat magnezijev sulfat heptahidrat kalijev klorid natrijev acetat trihidrat cinkov sulfat heptahidrat glukoza hidrat sojino ulje, rafinirano trigliceridi, srednje duljine lanca maslinovo ulje, rafinirano riblje ulje, obogaćeno omega-3 kiselinama - emulzija za infuziju - urbroj: 1026 ml emulzije sadrži 348 ml otopine aminokiselina + 478 ml otopine glukoze + 200 ml lipidne emulzije 1539 ml emulzije sadrži 522 ml otopine aminokiselina + 717 ml otopine glukoze + 300 ml lipidne emulzije 2052 ml emulzije sadrži 696 ml otopine aminokiselina + 956 ml otopine glukoze + 400 ml lipidne emulzije 2565 ml emulzije sadrži 870 ml otopine aminokiselina + 1195 ml otopine glukoze + 500 ml lipidne emulzije
amversio
serb sa - betaine - homocistinuriju - drugi gastrointestinalni trakt i metabolizam, lijekovi, - amversio is indicated as adjunctive treatment of homocystinuria, involving deficiencies or defects in:• cystathionine beta-synthase (cbs),• 5,10 methylene tetrahydrofolate reductase (mthfr),• cobalamin cofactor metabolism (cbl).
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinom, ne-malih stanica pluća - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
orserdu
stemline therapeutics b.v. - elacestrant - neoplazme dojki - endokrinska terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, mieloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
carbaglu
recordati rare diseases - karglumna kiselina - amino acid metabolism, inborn errors; propionic acidemia - drugi gastrointestinalni trakt i metabolizam, lijekovi, - carbaglu je indiciran u liječenju:hyperammonaemia komunikacije do n-acetylglutamate-sintaze primarni deficit;hyperammonaemia zbog изовалериановой acidaemia;hyperammonaemia zbog methymalonic acidaemia;hyperammonaemia zbog пропионовой acidaemia.
dobutamin admeda 5 mg/ml otopina za infuziju
medicuspharma d.o.o., rokov perivoj 6/a, zagreb, hrvatska - dobutaminklorid - otopina za infuziju - 5 mg/ml - urbroj: 1 bočica s 50 ml otopine za infuziju sadrži 250 mg dobutamina u obliku dobutaminklorida
dobutamin hameln 12,5 mg/ml koncentrat za otopinu za infuziju
hameln pharma gmbh, inselstrasse 1, hameln, njemačka - dobutaminklorid - koncentrat za otopinu za infuziju - 12,5 mg/ml - urbroj: 1 ml koncentrata za otopinu za infuziju sadrži 12,5 mg dobutamina